Literature DB >> 9545269

Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing.

M Hersberger1, T L Innerarity.   

Abstract

Normally, apolipoprotein B (apoB) mRNA editing deaminates a single cytidine (C6666) in apoB mRNA. However, when the catalytic subunit of the editing enzyme complex, APOBEC-1, was overexpressed in transgenic mice and rabbits, numerous cytidines in the apoB mRNA and in a novel mRNA, NAT1, were aberrantly hyperedited, and the animals developed liver dysplasia and hepatocellular carcinomas. To identify the RNA motifs in the apoB mRNA that support physiological editing and those that support aberrant hyperediting, we constructed rabbit apoB RNA substrates and tested them in vitro for physiological editing and hyperediting. Three previously unrecognized RNA elements that are critical for efficient physiological editing at C6666 were identified. In concert with the mooring sequence (6671-6681), the 5' efficiency element (6609-6628), an A-rich region (6629-6640), and the 3' efficiency element (6717-6747) increased editing at C6666. The 5' efficiency element was the most potent, elevating physiological editing to wild-type levels in combination with the mooring sequence. The 3' efficiency element was somewhat less important but increased physiological editing to levels approaching wild type. These elements encompass 139 nucleotides on the apoB RNA transcript and are sufficient for editing with the efficiency of full-length apoB mRNA. Furthermore, a distal downstream apoB region (6747-6824) may function as a recognition element in the apoB mRNA. Hyperediting at C6802 in the rabbit apoB mRNA is mediated by RNA elements similar to those required for normal physiological editing at C6666. Similarly sized upstream and downstream flanking regions of C6802 are necessary for hyperediting in combination with a degenerate mooring sequence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9545269     DOI: 10.1074/jbc.273.16.9435

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  The challenge of target sequence specificity in C-->U RNA editing.

Authors:  Nicholas O Davidson
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor.

Authors:  Christophe Maris; James Masse; Ann Chester; Naveenan Navaratnam; Frédéric H-T Allain
Journal:  RNA       Date:  2005-02       Impact factor: 4.942

3.  Hypermutation induced by APOBEC-1 overexpression can be eliminated.

Authors:  Zhigang Chen; Thomas L Eggerman; Alexander V Bocharov; Irina N Baranova; Tatyana G Vishnyakova; Gyorgy Csako; Amy P Patterson
Journal:  RNA       Date:  2010-03-26       Impact factor: 4.942

4.  Hippocampal Characteristics and Invariant Sequence Elements Distribution of GLRA2 and GLRA3 C-to-U Editing.

Authors:  Philipp Schaefermeier; Sarah Heinze
Journal:  Mol Syndromol       Date:  2016-12-16

5.  An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.

Authors:  S Anant; N O Davidson
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.

Authors:  Z Chen; T L Eggerman; A P Patterson
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

7.  C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.

Authors:  Debnath Mukhopadhyay; Shrikant Anant; Robert M Lee; Susan Kennedy; David Viskochil; Nicholas O Davidson
Journal:  Am J Hum Genet       Date:  2001-11-27       Impact factor: 11.025

8.  Tissue-specific modification of gld-2 mRNA in C. elegans: likely C-to-U editing.

Authors:  Liaoteng Wang; Judith Kimble; Marvin Wickens
Journal:  RNA       Date:  2004-09       Impact factor: 4.942

9.  Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF.

Authors:  Ann Chester; Violetta Weinreb; Charles W Carter; Naveenan Navaratnam
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

10.  The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay.

Authors:  Ann Chester; Angelika Somasekaram; Maria Tzimina; Adam Jarmuz; Jane Gisbourne; Raymond O'Keefe; James Scott; Naveenan Navaratnam
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.